Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro-Reference-Cited by-同舟云学术

Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro

Published:2018-07-12 Issue:8 Volume:4 Page:1264-1274
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Radke Joshua B.¹,Burrows Jeremy N.²,Goldberg Daniel E.³,Sibley L. David¹^ORCID

Affiliation:

1. Department of Molecular Microbiology, Washington University School of Medicine in St. Louis, 600 S. Euclid Avenue, St. Louis, Missouri 63110, United States

2. Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, 1215 Geneva, Switzerland

3. Departments of Medicine and Molecular Microbiology, Washington University School of Medicine in St. Louis, 660 S. Euclid Avenue, St. Louis, Missouri 63110, United States

Funder

U.S. Department of Health and Human Services

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.8b00113

Reference87 articles.

1. Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes

2. THE TOXOPLASMA GONDII OOCYST FROM CAT FECES

3. Toxoplasma gondii : Fecal Forms Separated from Eggs of the Nematode Toxocara cati